Home

carski razumjeti Klan teva fda warning svezak neprekidan krumpir

Teva halts output at U.S. drug plant after FDA flags concerns | Reuters
Teva halts output at U.S. drug plant after FDA flags concerns | Reuters

FDA approves first generic version of epilepsy drug Sabril from Teva
FDA approves first generic version of epilepsy drug Sabril from Teva

Teva recalls U.S.-made drugs following contamination fears | Pittsburgh  Post-Gazette
Teva recalls U.S.-made drugs following contamination fears | Pittsburgh Post-Gazette

FDA Recalls Valsartan-Containing Drugs After Detection of Carcinogen |  tctmd.com
FDA Recalls Valsartan-Containing Drugs After Detection of Carcinogen | tctmd.com

FDA Warns Against Use of Fake ADHD Drug Adderall
FDA Warns Against Use of Fake ADHD Drug Adderall

Dexamethasone benefits severely ill Covid patients, FDA warning letter to  Takeda's sterile operations in Japan | Radio Compass Blog
Dexamethasone benefits severely ill Covid patients, FDA warning letter to Takeda's sterile operations in Japan | Radio Compass Blog

Teva sues FDA for changing 'first applicant' definition for generics
Teva sues FDA for changing 'first applicant' definition for generics

FDA Bans Imports From Teva's Hungary Plant Except Two Drugs in Shortage |  RAPS
FDA Bans Imports From Teva's Hungary Plant Except Two Drugs in Shortage | RAPS

FDA предупреждает «Teva» о существенных нарушениях на производстве |  Еженедельник АПТЕКА
FDA предупреждает «Teva» о существенных нарушениях на производстве | Еженедельник АПТЕКА

Teva plant tagged with warning letter for issues making schizophrenia drug  | FiercePharma
Teva plant tagged with warning letter for issues making schizophrenia drug | FiercePharma

FDA Warning Letter To Teva Highlights Need For Accurate Root Cause  Investigations :: Pink Sheet
FDA Warning Letter To Teva Highlights Need For Accurate Root Cause Investigations :: Pink Sheet

Teva receives warning letter over Actavis site
Teva receives warning letter over Actavis site

Teva confirms US FDA warning letter for Hangzhou, China API plant
Teva confirms US FDA warning letter for Hangzhou, China API plant

Teva's rating cut to junk, Two Lupin facilities receive FDA warning letters  | Radio Compass Blog
Teva's rating cut to junk, Two Lupin facilities receive FDA warning letters | Radio Compass Blog

Teva confident in September approval for migraine drug despite latest  Celltrion plant citation - PSC Biotech Singapore
Teva confident in September approval for migraine drug despite latest Celltrion plant citation - PSC Biotech Singapore

FDA Regulation of Promotion & Advertising -- Part 4: FDA Enforcement…
FDA Regulation of Promotion & Advertising -- Part 4: FDA Enforcement…

FDA issues counterfeit Adderall warning - PMLiVE
FDA issues counterfeit Adderall warning - PMLiVE

Teva China API plant smacked by FDA warning letter, adding to drugmaker's  burdens
Teva China API plant smacked by FDA warning letter, adding to drugmaker's burdens

UPDATED: Teva's struggling sterile plant hit with FDA warning letter |  FiercePharma
UPDATED: Teva's struggling sterile plant hit with FDA warning letter | FiercePharma

Lawsuits Mount Over Cancer Drug's FDA Black Box Warning - Drug And Device  Watch
Lawsuits Mount Over Cancer Drug's FDA Black Box Warning - Drug And Device Watch

Teva Initiates Voluntary Nationwide Recall of One Lot of Topotecan  Injection 4 mg/4 mL (1 mg/mL) Due to Presence of Particulate Matter | FDA
Teva Initiates Voluntary Nationwide Recall of One Lot of Topotecan Injection 4 mg/4 mL (1 mg/mL) Due to Presence of Particulate Matter | FDA

FDA warning: counterfeit version of Teva's Adderall - Consumer Med Safety
FDA warning: counterfeit version of Teva's Adderall - Consumer Med Safety

Teva wins FDA nod for sublingual film to treat opioid dependence - Drug  Delivery Business
Teva wins FDA nod for sublingual film to treat opioid dependence - Drug Delivery Business

Teva Recalls U.S.-Made Drugs Following Contamination Fears
Teva Recalls U.S.-Made Drugs Following Contamination Fears

FDA Approves Biosimilar, But it Comes with a Severe Label Warning |  Packaging World
FDA Approves Biosimilar, But it Comes with a Severe Label Warning | Packaging World